Violation of drugs patents: Boehringer Ingelheim demands mechanisms in place
Drug major Boehringer Ingelheim India has urged authorities to put in place a system that will inform patent holders whenever an application is filed by local brands for generic versions of patented molecules. The demand of the company, which is part of Germany's privately-held Boehringer Ingelheim, also comes at a time when there are rising concerns over patent infringements and copyright violations in various sectors, including the fast growing pharma space.
Boehringer Ingelheim India Managing Director Vani Manja noted that currently the burden is on the innovator to first get the patent then keep a check for any infringement.
For more information, check out the full story on the link below: